Drug development and the biopharmaceutical industry as a whole continues to expand, employing more people and increasing in total market value year after year. How is this evolving landscape affecting companies along the continuum, such as contract research organizations (CRO) and other life science service providers? BioCrossroads will bring together industry leaders, including Pearl IRB’s President & CEO Diana Caldwell, to discuss a range of topics related to the burgeoning biopharma industry in Indiana and how the growth of the industry is impacting local companies.
What: BioCrossroads panel discussion – “Biopharma Drug Development: How is the Evolving Landscape Affecting Companies Along the Continuum?”
Where: Butler University Fairview House Community Room – 4550 Sunset Ave. Indianapolis, IN 46208
When: Tuesday, April 17, 2018. 8:00 am – 10:00 am EST
Read the full session description and register for the April BioCrossroads session.
BioCrossroads advances Indiana’s signature strengths in the life sciences by connecting with corporate, academic and philanthropic partners; facilitating investments in promising start ups and building new enterprises; and educating through conferences, reports and market development knowledge. Learn more about BioCrossroads here.